linkedin

Press Releases

News Brief

Samsung Biologics participates in CPhI Worldwide 2021

CPhI_211109_004-S.png
 

Samsung Biologics is participating in CPhI Worldwide 2021, which is taking place in-person from November 9-11, 2021 at Fiera Milano, Italy. As the world's largest pharmaceutical exhibition, CPhI Worldwide will be a host to more than 2,500 companies with more than 48,000 pharma industry leaders attending, providing an industry-leading setting to network and share insights. 

 

The company will showcase its progresses and achievements at an independent exhibition booth. A panoramic display will be exhibited to highlight some of the key capabilities of Samsung Biologics as a leading CDMO. The core focuses will be, 'Samsung Biologics world's largest manufacturing capacity of 620,000L', 'S-Cellerate (CDO process platform to expedite timeline to IND and BLA)', 'Multi-modality for business portfolio expansion', and 'Offering of end-to-end, one-stop service'. 

 

Samsung Biologics will follow the guidelines to help prevent the spread of COVID-19 and advise all attendees to be wearing masks when visiting the booth.  

CPhI_211109_004-S.png
 

Samsung Biologics is participating in CPhI Worldwide 2021, which is taking place in-person from November 9-11, 2021 at Fiera Milano, Italy. As the world's largest pharmaceutical exhibition, CPhI Worldwide will be a host to more than 2,500 companies with more than 48,000 pharma industry leaders attending, providing an industry-leading setting to network and share insights. 

 

The company will showcase its progresses and achievements at an independent exhibition booth. A panoramic display will be exhibited to highlight some of the key capabilities of Samsung Biologics as a leading CDMO. The core focuses will be, 'Samsung Biologics world's largest manufacturing capacity of 620,000L', 'S-Cellerate (CDO process platform to expedite timeline to IND and BLA)', 'Multi-modality for business portfolio expansion', and 'Offering of end-to-end, one-stop service'. 

 

Samsung Biologics will follow the guidelines to help prevent the spread of COVID-19 and advise all attendees to be wearing masks when visiting the booth. 

SITE MAP

close
Close

Thank you for Subscribing to Our Newsletter

아래 다운로드 버튼을 클릭하시면 바로 다운로드 하실 수 있습니다.

Close

Subscribe to Our Newsletter

파일 다운로드를 위해 뉴스레터 구독용 이메일 주소를 입력해주세요.
* 구독자라면 구독중인 이메일 주소를 입력해주세요.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

뉴스레터 구독 서비스를 등록하시면 당사 뉴스룸에서 제공되는
삼성바이오로직스의 최신 소식과 관심 분야별 유용한 정보를 받아 보실 수 있습니다.

Subscribe to Our Newsletter
    • - 개인정보 수집 목적 : 이메일 발신서비스 제공
    • - 개인정보 수집 항목 : 이메일 주소, 회사명, 이름, 직급, 국가
    • - 이용 및 보관 기간 : 이메일 발신서비스 해지 시까지

    개인정보 수집에 동의하지 않을 시, 뉴스레터 서비스를 이용할 수 없습니다.

    삼성바이오로직스 개인정보 보호정책에 따라 개인정보는 안전하게 관리됩니다.

close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved